OTCMKTS:ERFSF - Eurofins Scientific Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $96.25
  • Forecasted Upside: 24.26 %
  • Number of Analysts: 9
  • Breakdown:
  • 1 Sell Ratings
  • 5 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$77.46
▲ +0.36 (0.47%)

This chart shows the closing price for ERFSF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Eurofins Scientific Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ERFSF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ERFSF

Analyst Price Target is $96.25
▲ +24.26% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Eurofins Scientific in the last 3 months. The average price target is $96.25, with a high forecast of $110.00 and a low forecast of $70.00. The average price target represents a 24.26% upside from the last price of $77.46.

This chart shows the closing price for ERFSF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 9 contributing investment analysts is to hold stock in Eurofins Scientific. This rating has held steady since July 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
2/17/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/18/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings
8/16/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings
11/14/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 1 sell ratings
2/12/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 1 sell ratings
5/13/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 1 sell ratings
7/12/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 1 sell ratings
8/11/2022

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/28/2022Societe GeneraleDowngradeHold ➝ Sell
7/8/2022Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight€95.00 ➝ €70.00
6/23/2022Deutsche Bank AktiengesellschaftUpgradeSell ➝ Hold
6/17/2022Societe GeneraleDowngradeBuy ➝ Hold
4/8/2022HSBCUpgradeReduce ➝ Hold
2/24/2022Credit Suisse GroupLower Price TargetOutperform ➝ Outperform€125.00 ➝ €110.00
2/24/2022BarclaysLower Price Target€125.00 ➝ €105.00
2/24/2022Berenberg BankUpgradeHold ➝ Buy
2/3/2022The Goldman Sachs GroupUpgradeNeutral ➝ Buy
1/18/2022Berenberg BankLower Price Target€105.00 ➝ €100.00
1/10/2022Jefferies Financial GroupDowngradeBuy ➝ Hold
12/1/2021The Goldman Sachs GroupDowngradeBuy ➝ Neutral
12/1/2021Morgan StanleyReiterated RatingEqual Weight
10/18/2021Berenberg BankDowngradeBuy ➝ Hold
8/25/2021Bryan, Garnier & CoDowngradeStrong-Buy ➝ Neutral
8/11/2021Morgan StanleyReiterated RatingEqual Weight
8/9/2021Deutsche Bank AktiengesellschaftReiterated RatingSell
8/6/2021Credit Suisse GroupReiterated RatingOutperform
8/6/2021Societe GeneraleReiterated RatingBuy
7/28/2021HSBCDowngradeReduce
7/9/2021Bryan, Garnier & CoDowngradeBuy ➝ Neutral
12/3/2020Morgan StanleyDowngradeEqual Weight ➝ Underweight
10/16/2020BarclaysInitiated CoverageOverweight
8/11/2020Berenberg BankReiterated RatingBuy
8/10/2020Deutsche Bank AktiengesellschaftReiterated RatingSell
8/10/2020Credit Suisse GroupReiterated RatingOutperform
5/27/2020Jefferies Financial GroupUpgradeHold ➝ Buy
3/11/2020Morgan StanleyUpgradeUnderweight ➝ Equal Weight
2/14/2020Deutsche Bank AktiengesellschaftInitiated CoverageSell
1/16/2020BNP ParibasDowngradeNeutral ➝ Underperform
3/20/2019Jefferies Financial GroupDowngradeBuy ➝ Hold
11/26/2018Berenberg BankUpgradeHold ➝ Buy
(Data available from 8/12/2017 forward)

News Sentiment Rating

0.23 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/14/2022
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/13/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/15/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/14/2022
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/14/2022
  • 3 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/13/2022
  • 3 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
7/13/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/12/2022

Current Sentiment

  • 0 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Eurofins Scientific logo
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agro-science, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, labelling, law, heavy metals, identity preservation, mealtime, molecular and microbiology, mycotoxins, nutritional analyses, organic containments, packaging/migration, radioactivity, rapidest, sensorsy and consumer research, trainings, veterinary drug residues, and vitamins services. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. It operates approximately 900 laboratories in 54 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
Read More

Today's Range

Now: $77.46
Low: $77.46
High: $77.46

50 Day Range

MA: $80.80
Low: $75.63
High: $92.55

52 Week Range

Now: $77.46
Low: $75.32
High: $151.96

Volume

9 shs

Average Volume

452 shs

Market Capitalization

$13.79 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.81

Frequently Asked Questions

What sell-side analysts currently cover shares of Eurofins Scientific?

The following Wall Street research analysts have issued reports on Eurofins Scientific in the last year: Barclays PLC, Berenberg Bank, Bryan, Garnier & Co, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, HSBC Holdings plc, Jefferies Financial Group Inc., Morgan Stanley, Societe Generale, and The Goldman Sachs Group, Inc..
View the latest analyst ratings for ERFSF.

What is the current price target for Eurofins Scientific?

4 Wall Street analysts have set twelve-month price targets for Eurofins Scientific in the last year. Their average twelve-month price target is $96.25, suggesting a possible upside of 24.3%. Credit Suisse Group AG has the highest price target set, predicting ERFSF will reach $110.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $70.00 for Eurofins Scientific in the next year.
View the latest price targets for ERFSF.

What is the current consensus analyst rating for Eurofins Scientific?

Eurofins Scientific currently has 1 sell rating, 5 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ERFSF, but not buy more shares or sell existing shares.
View the latest ratings for ERFSF.

What other companies compete with Eurofins Scientific?

How do I contact Eurofins Scientific's investor relations team?

Eurofins Scientific's physical mailing address is 23 Val Fleuri, Luxembourg N4, 1526. The company's listed phone number is (522) 618-5320 and its investor relations email address is [email protected] The official website for Eurofins Scientific is www.eurofins.com. Learn More about contacing Eurofins Scientific investor relations.